← Leaderboards
D. Keith Bishop
University Of Michigan At Ann Arbor
$8,118,791
Attributed
$8,118,791
Total exposure
5
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $702.2K · FY2005–14$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
Funding mix
By agency
NIH$8,118,791 · 5
By mechanism
R01$7,308,327 · 3
P01$440,198 · 1
R56$370,266 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Michigan At Ann Arbor
Same institution · by research overlap
- Guohua Xi$18,510,581
- Ruma V Banerjee$24,139,300
- David J. Pinsky$32,329,328
- Susan V Brooks$11,089,591
- Ken A. Resnicow$20,635,088
Others in their field
Top investigators on “Helper T Lymphocyte”
- Barton F Haynes · Duke University$197,687,138
- Kent J. Weinhold · Duke University$45,701,691
- Louis J. Picker · Oregon Health And Science University$38,911,409
- Shane P Crotty · Scripps Research Institute, The$33,497,396
- Rafi Ahmed · Emory University$29,790,941
- Robert A Wood · Johns Hopkins University$25,022,096
Research focus
Helper T LymphocyteCytokineCytotoxic T LymphocyteDecorinHeart TransplantationFibrosisHomologous TransplantationTransplantationScid MouseAllograftingGene ExpressionResponseHeart AllograftTransplant RejectionT-LymphocyteEffector CellMediatingCellsInsightGene TherapyChronicConnective Tissue Growth FactorElementsTransforming Growth Factors
Grant awards (26)
Therapeutic Targets for Chronic Allograft Rejection$380,975
R01 · FY2014 · HL · contact PI
Therapeutic Targets for Chronic Allograft Rejection$370,090
R01 · FY2013 · HL · contact PI
Therapeutic Targets for Chronic Allograft Rejection$388,750
R01 · FY2012 · HL · contact PI
Therapeutic Targets for Chronic Allograft Rejection$387,500
R01 · FY2011 · HL · contact PI
CD8+ Th17 and Costimulation Blockade Resistant Allograft Rejection$370,266
R56 · FY2010 · AI · contact PI
Therapeutic Targets for Chronic Allograft Rejection$357,725
R01 · FY2009 · HL · contact PI
Therapeutic Targets for Chronic Allograft Rejection$357,982
R01 · FY2008 · HL · contact PI
Roles of CD40 and CD40 Ligand in Allograft Rejection$302,818
R01 · FY2008 · AI · contact PI
Therapeutic Targets for Chronic Allograft Rejection$323,622
R01 · FY2007 · HL · contact PI
Roles of CD40 and CD40 Ligand in Allograft Rejection$310,516
R01 · FY2007 · AI · contact PI
Therapeutic Targets for Chronic Allograft Rejection$382,375
R01 · FY2006 · HL · contact PI
Roles of CD40 and CD40 Ligand in Allograft Rejection$319,790
R01 · FY2006 · AI · contact PI
Therapeutic Targets for Chronic Allograft Rejection$368,826
R01 · FY2005 · HL
Roles of CD40 and CD40 Ligand in Allograft Rejection$327,485
R01 · FY2005 · AI
Therapeutic Targets for Chronic Allograft Rejection$369,159
R01 · FY2004 · HL
Roles of CD40 and CD40 Ligand in Allograft Rejection$339,410
R01 · FY2004 · AI
Therapeutic Targets for Chronic Allograft Rejection$369,480
R01 · FY2003 · HL
TGFB1 GENE TRANSFER IN VASCULARIZED CARDIAC ALLOGRAFTS$340,071
R01 · FY2003 · AI
Therapeutic Targets for Chronic Allograft Rejection$369,789
R01 · FY2002 · HL
TGFB1 GENE TRANSFER IN VASCULARIZED CARDIAC ALLOGRAFTS$310,205
R01 · FY2002 · AI
TGFB1 GENE TRANSFER IN VASCULARIZED CARDIAC ALLOGRAFTS$320,548
R01 · FY2001 · AI
CORE--CLINICAL IMMUNOLOGY AND DIAGNOSTICS$0
P01 · FY2001 · AI
CORE--CLINICAL IMMUNOLOGY AND DIAGNOSTICS$0
P01 · FY2001 · AI
TGFB1 GENE TRANSFER IN VASCULARIZED CARDIAC ALLOGRAFTS$311,211
R01 · FY2000 · AI
CORE--CLINICAL IMMUNOLOGY AND DIAGNOSTICS$220,099
P01 · FY2000 · AI
CORE--CLINICAL IMMUNOLOGY AND DIAGNOSTICS$220,099
P01 · FY2000 · AI